Blood sugar monitoring system approved for children

(HealthDay)—U.S. Food and Drug Administration approval of the Dexcom G4 Platinum Continuous Monitoring System has been expanded to include children with diabetes aged 2 years to 17 years, the agency said.

Previously approved for adults only, the device constantly monitors the user's blood sugar, checking for dangerously high or low levels, the FDA said in a news release. An estimated 25.8 million people in the United States—including 215,000 under age 20—have diabetes.

The external device, known as a continuous glucose monitor, includes a small, narrow sensor that's inserted just under the skin. That combined with a blood glucose meter can help the user's doctor decide , such as the amount of insulin to prescribe, the FDA said.

The device was evaluated in clinical studies involving 176 people ages 2 to 17. The FDA warned the device's "performance in pediatric subjects was not as accurate as the performance of the same device in adults." Nonetheless, the agency said the device is still "effective for tracking and trending to determine patterns in ," and for warning users that their had risen too high or fallen too low.

The system is produced by Dexcom Inc., based in San Diego.

More information: The FDA has more about this approval.

add to favorites email to friend print save as pdf

Related Stories

Blood-tracking device uses new technology

May 29, 2013

(HealthDay)—The first device to use Radio Frequency Identification (RFID) technology to help workers track blood products and prevent the release of unsuitable samples has been approved by the U.S. Food and Drug Administration.

FDA approves new magnet device to treat migraines

Dec 15, 2013

(HealthDay)—The U.S. Food and Drug Administration has approved the first device aimed at easing the pain of migraines preceded by aura—sensory disturbances that occur just before an attack.

Stent to treat pancreatic cysts approved

Dec 19, 2013

(HealthDay)—The Axios Stent and Delivery System has been approved by the U.S. Food and Drug Administration to treat infected pancreatic cysts that won't drain on their own and could become life threatening, the FDA said ...

Recommended for you

FDA OKs Cubist antibiotic for serious infections

17 hours ago

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.